Literature DB >> 1534116

Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.

E Barzaga-Gilbert1, D Grass, S K Lawrance, P A Peterson, E Lacy, V H Engelhard.   

Abstract

Murine T cell responses to human class II major histocompatibility complex (MHC) molecules were shown to be a minimum of 20-70-fold lower than responses to allogeneic molecules. Transgenic mice expressing slightly below normal (75-95%) or very high (250-380%) cell surface levels of human CD4 were utilized to determine whether this was due to a species-specific interaction between murine CD4 and class II molecules. Human CD4 was shown to function in signal transduction events in murine T cells based on the ability of anti-human CD4 antibody to synergize with suboptimal doses of anti-murine CD3 antibody in stimulating T cell proliferation. In mice expressing lower levels of human CD4, T cell responses to human class II molecules were enhanced up to threefold, whereas allogeneic responses were unaltered. In mice expressing high levels of human CD4, responses to human class II molecules were enhanced at least 10-fold, whereas allogeneic responses were between one and three times the level of normal responses. The relatively greater enhancement of the response to human class II molecules in both lines argues for a preferential interaction between human CD4 and human class II molecules. In mice expressing lower levels of human CD4, responses to human class II molecules were blocked by antibodies to CD4 of either species, indicating participation by both molecules. In mice expressing high levels of human CD4, responses to both human and murine class II molecules were almost completely blocked with anti-human CD4 antibody, whereas anti-murine CD4 antibody had no effect. However, anti-murine CD4 continued to synergize with anti-CD3 in stimulating T cell proliferation in these mice. Thus, overexpression of human CD4 selectively impaired the ability of murine CD4 to assist in the process of antigen recognition. The ability of human CD4 to support a strong allogeneic response under these conditions indicates that this molecule can interact with murine class II molecules to a significant extent. Despite the fact that human CD4 appeared to be the only functional coreceptor in these mice, responses to human class II molecules were still much lower than those to murine class II alloantigens. This indicates that species-specific interactions between class II molecules and CD4 expressed on peripheral T cells are not sufficient to account for the low xenogeneic response and that intrinsic differences in T cell receptor structures or the need for species specificity in the interaction between CD4 and class II molecules during positive selection are also important.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534116      PMCID: PMC2119243          DOI: 10.1084/jem.175.6.1707

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line.

Authors:  Y Shimizu; R DeMars
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

2.  Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.

Authors:  A X Le; E J Bernhard; M J Holterman; S Strub; P Parham; E Lacy; V H Engelhard
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

3.  Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.

Authors:  H S Teh; P Kisielow; B Scott; H Kishi; Y Uematsu; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

4.  Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens.

Authors:  V H Engelhard; C Benjamin
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand.

Authors:  L J Berg; A M Pullen; B Fazekas de St Groth; D Mathis; C Benoist; M M Davis
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

6.  The MHC-binding and gp120-binding functions of CD4 are separable.

Authors:  D Lamarre; A Ashkenazi; S Fleury; D H Smith; R P Sekaly; D J Capon
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

7.  The alpha 3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation.

Authors:  N L Samberg; E C Scarlett; H J Stauss
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

8.  Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.

Authors:  K Yoshizawa; A Yano
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

9.  Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.

Authors:  M J Irwin; W R Heath; L A Sherman
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridoma.

Authors:  P von Hoegen; M C Miceli; B Tourvieille; M Schilham; J R Parnes
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  11 in total

1.  Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120.

Authors:  J Seagal; E Spectorman; J M Gershoni; G F Denisova
Journal:  Transgenic Res       Date:  2001-04       Impact factor: 2.788

2.  Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes.

Authors:  A C Cunningham; T J Butler; J A Kirby
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

3.  A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.

Authors:  Xiangming Li; Jing Huang; Izumi Kaneko; Min Zhang; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Expert Rev Vaccines       Date:  2016-11-16       Impact factor: 5.217

4.  Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.

Authors:  R S Yeung; J M Penninger; T M Kündig; Y Law; K Yamamoto; N Kamikawaji; L Burkly; T Sasazuki; R Flavell; P S Ohashi; T W Mak
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

5.  Human CD4 produced in lymphoid cells of transgenic mice binds HIV gp120 and modifies the subsets of mouse T-cell populations.

Authors:  P Forte; A Aiuti; L Pozzi; F Citarella; A Fattorossi; G B Rossi; A Fantoni
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 6.  Human intrathymic development: a selective approach.

Authors:  J Plum; M De Smedt; G Leclercq; T Taghon; T Kerre; B Vandekerckhove
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

7.  Human CD4 restores normal T cell development and function in mice deficient in murine CD4.

Authors:  Y M Law; R S Yeung; C Mamalaki; D Kioussis; T W Mak; R A Flavell
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

8.  Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.

Authors:  S Sawada; K Gowrishankar; R Kitamura; M Suzuki; G Suzuki; S Tahara; A Koito
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

9.  Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.

Authors:  N Killeen; S Sawada; D R Littman
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

10.  Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.

Authors:  K Yamamoto; Y Fukui; Y Esaki; T Inamitsu; T Sudo; K Yamane; N Kamikawaji; A Kimura; T Sasazuki
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.